< CE News
Examining Treatment Options in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Review for Specialty Pharmacists
Thu, Feb 28, 2019 11:09 PM UTC
Date: Thursday, May 2, 2019
Location: Wynn and Encore Hotels
3131 S Las Vegas Boulevard
Las Vegas, Nevada 89109
Time: 12:00 pm – 1:30 pm
*Lunch will be available
Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease with just a 50% two-year survival rate from diagnosis to death. Until recently, there were no approved pharmacologic treatments for CTEPH. Traditionally, medications approved for pulmonary arterial hypertension are used to treat CTEPH off-label due to the similarity of the pathophysiology of the 2 diseases. Specialty pharmacists have a valuable role to guide appropriate medication use that is both safe and effective. With proper knowledge, pharmacists will be familiar with recent guidelines, best practices, and the range of therapeutic options to optimize patient care while minimizing health care utilization.
- Identify the progression and evolution of venous thromboembolism to CTEPH and its impact on patient care
- Explain efficacy and safety data of current and emerging CTEPH therapies
- Examine the role of the specialty pharmacist in transitions of care and outpatient management
Rebekah H. Anguiano, PharmD, BCPS, BCACP
Clinical Pharmacist and Assistant Professor
University of Illinois Hospital and Health Sciences System
Christopher Ensor, PharmD, BCPS, FAST, FCCP
Clinical Coordinator, Pharmacy
Advent Health Orlando
This activity is supported by an educational grant from Actelion.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-19-051-L01-P. The activity is available for CE credit for May 2, 2019.
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Detailed instructions on obtaining credit will be provided at the session. Credit must be requested no later than July 2, 2019.